Total Payments
$1.0M
2024 Payments
$88,336
Companies
53
Transactions
1,904
Medicare Patients
715
Medicare Billing
$73,272
Payment Breakdown by Category
Other$811,289 (80.1%)
Travel$112,030 (11.1%)
Consulting$52,449 (5.2%)
Food & Beverage$36,297 (3.6%)
Education$234.41 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $767,231 | 328 | 75.8% |
| Travel and Lodging | $112,030 | 251 | 11.1% |
| Consulting Fee | $52,449 | 21 | 5.2% |
| Honoraria | $44,059 | 20 | 4.4% |
| Food and Beverage | $36,297 | 1,274 | 3.6% |
| Education | $234.41 | 10 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $297,700 | 272 | $0 (2019) |
| Mallinckrodt Enterprises LLC | $223,927 | 240 | $0 (2019) |
| ABBVIE INC. | $129,810 | 276 | $0 (2024) |
| Amgen Inc. | $75,361 | 186 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $64,003 | 71 | $0 (2024) |
| Lilly USA, LLC | $53,785 | 128 | $0 (2023) |
| GlaxoSmithKline, LLC. | $33,488 | 61 | $0 (2024) |
| Horizon Therapeutics plc | $30,519 | 56 | $0 (2023) |
| GENZYME CORPORATION | $29,907 | 38 | $0 (2024) |
| PFIZER INC. | $16,031 | 140 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $88,336 | 101 | ABBVIE INC. ($32,663) |
| 2023 | $78,903 | 173 | Horizon Therapeutics plc ($24,226) |
| 2022 | $94,368 | 263 | ABBVIE INC. ($26,957) |
| 2021 | $49,261 | 164 | Mallinckrodt Hospital Products Inc. ($12,879) |
| 2020 | $68,491 | 190 | Mallinckrodt Hospital Products Inc. ($24,071) |
| 2019 | $215,403 | 363 | Celgene Corporation ($99,434) |
| 2018 | $214,714 | 357 | Celgene Corporation ($112,851) |
| 2017 | $202,823 | 293 | Mallinckrodt LLC ($87,503) |
All Payment Transactions
1,904 individual payment records from CMS Open Payments — Page 1 of 77
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/11/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/10/2024 | PFIZER INC. | XELJANZ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,125.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/10/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,860.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $120.10 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/28/2024 | PFIZER INC. | XELJANZ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/26/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/21/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,860.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $337.50 | General |
| Category: Inflammation | ||||||
| 11/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: Immunology | ||||||
| 11/17/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $28.86 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $138.60 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/15/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $37.38 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Inflammation | ||||||
| 10/21/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $37.46 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Bone Health | ||||||
| 10/15/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Travel and Lodging | Cash or cash equivalent | $134.00 | General |
| Category: Inflammation/Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 175 | 289 | $82,249 | $19,264 |
| 2022 | 2 | 207 | 278 | $58,974 | $19,677 |
| 2021 | 3 | 159 | 266 | $47,830 | $17,677 |
| 2020 | 3 | 174 | 283 | $63,705 | $16,654 |
Total Patients
715
Total Services
1,116
Medicare Billing
$73,272
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 146 | 258 | $68,645 | $16,278 | 23.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 31 | $13,604 | $2,986 | 21.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 135 | 203 | $37,171 | $12,960 | 34.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 72 | 75 | $21,803 | $6,717 | 30.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 115 | 206 | $36,874 | $14,359 | 38.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 28 | 29 | $10,150 | $3,115 | 30.7% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2021 | 16 | 31 | $806.00 | $203.58 | 25.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 132 | 241 | $49,950 | $13,093 | 26.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 27 | 27 | $9,450 | $2,470 | 26.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 15 | 15 | $4,305 | $1,091 | 25.3% |
About Dr. Aarat Patel, MD
Dr. Aarat Patel, MD is a Pediatric Rheumatology healthcare provider based in Charlottesville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/15/2008. The National Provider Identifier (NPI) number assigned to this provider is 1528203874.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aarat Patel, MD has received a total of $1.0M in payments from pharmaceutical and medical device companies, with $88,336 received in 2024. These payments were reported across 1,904 transactions from 53 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($767,231).
As a Medicare-enrolled provider, Patel has provided services to 715 Medicare beneficiaries, totaling 1,116 services with total Medicare billing of $73,272. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Pediatric Rheumatology
- Other Specialties Rheumatology
- Location Charlottesville, VA
- Active Since 12/15/2008
- Last Updated 02/03/2026
- Taxonomy Code 2080P0216X
- Entity Type Individual
- NPI Number 1528203874
Products in Payments
- Otezla (Drug) $333,077
- ACTHAR (Biological) $287,930
- KRYSTEXXA (Biological) $56,126
- RINVOQ (Biological) $50,999
- TALTZ (Drug) $43,065
- BENLYSTA (Biological) $33,488
- SKYRIZI (Biological) $24,204
- Humira (Biological) $19,557
- PURIFIED CORTROPHIN GEL (Drug) $19,426
- Rinvoq (Biological) $19,380
- KEVZARA (Biological) $16,895
- XELJANZ (Drug) $15,507
- KEVZARA (Drug) $10,574
- KEVZARA SARILUMAB INJECTION (Biological) $10,191
- Otezla (Biological) $9,657
- Rasuvo (Drug) $6,047
- NO PRODUCT DISCUSSED (Drug) $6,013
- ILARIS (Biological) $5,914
- Enbrel (Biological) $1,165
- COSENTYX (Biological) $757.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.